Bruno Ricardo Pires

13PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical bacteriologyHaematological tumoursCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 08, 2026
Synergistic Cytotoxicity of Cafestol and Kahweol With Doxorubicin in Breast Cancer Cells Involves TNF‑α Targeting and NF‑κB Downregulation.

|Feb 23, 2025
Low-Power Blue LED Modulates NF-κB and Proinflammatory Cytokines in Doxorubicin-Treated MDA-MB-231 Cells.

Adilson Fonseca Teixeira, Bruno Ricardo Barreto Pires, Carolina Panis

|Nov 09, 2024
The Role of the Microbiome and of Radiotherapy-Derived Metabolites in Breast Cancer.

Lourdes Herrera-Quintana, Héctor Vázquez-Lorente, Rafael Cardoso Maciel Costa Silva

|Oct 13, 2024
APX2009 sensitizes hypoxic breast cancer cells to doxorubicin by increasing its accumulation and caspase-3/7-mediated apoptosis.

Ísis Salviano Soares de Amorim, Daphne Pinheiro, Matheus da Silva Oliveira

|May 29, 2024
The inhibitor of the redox activity of APE1/REF-1, APX2009, reduces the malignant phenotype of breast cancer cells.

P B Siqueira, M M S Rodrigues, Ĺ S S de Amorim

|May 22, 2024
Does photobiomodulation alter mitochondrial dynamics?

Larissa Alexsandra da Silva Neto Trajano, Priscyanne Barreto Siqueira, Mariana Moreno de Sousa Rodrigues

Pageof 3

Frequent Collaborators

5 joint publications

Adenilson de Souza da Fonseca

5 joint publications

Andre Luiz Mencalha

4 joint publications

Carolina Panis

3 joint publications

Priscyanne Barreto Siqueira